La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.

Identifieur interne : 000065 ( Hal/Curation ); précédent : 000064; suivant : 000066

Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.

Auteurs : Alireza Kashani [France] ; Catalina Betancur [France] ; Bruno Giros [France] ; Etienne Hirsch [France] ; Salah El Mestikawy [France]

Source :

RBID : Hal:inserm-00154872

English descriptors

Abstract

Glutamatergic pathways play a key role in the functional organization of neuronal circuits involved in Parkinson disease (PD). Recently, three vesicular glutamate transporters (VGLUT1-3) were identified. VGLUT1 and VGLUT2 are responsible for the uploading of glutamate into synaptic vesicles and are the first specific markers of glutamatergic neurons available. Here, we analyzed the expression of VGLUT1 and VGLUT2 in autopsy tissues of PD patients and matched controls using Western blot and immunoautoradiography. VGLUT1 and VGLUT2 expression was increased in the Parkinsonian putamen by 24% and 29%, respectively (p<0.01). In contrast, only VGLUT1 was dramatically decreased in the prefrontal and temporal cortex of PD patients (approximately 50%, p<0.01 and p<0.001, respectively). These findings demonstrate the existence of profound alterations of glutamatergic transmission in PD, which are likely to contribute to the motor and cognitive impairments associated with the disease, and should thus be taken into account in the treatment of PD.

Url:
DOI: 10.1016/j.neurobiolaging.2006.02.010

Links toward previous steps (curation, corpus...)


Links to Exploration step

Hal:inserm-00154872

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.</title>
<author>
<name sortKey="Kashani, Alireza" sort="Kashani, Alireza" uniqKey="Kashani A" first="Alireza" last="Kashani">Alireza Kashani</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Betancur, Catalina" sort="Betancur, Catalina" uniqKey="Betancur C" first="Catalina" last="Betancur">Catalina Betancur</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Giros, Bruno" sort="Giros, Bruno" uniqKey="Giros B" first="Bruno" last="Giros">Bruno Giros</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, Etienne" sort="Hirsch, Etienne" uniqKey="Hirsch E" first="Etienne" last="Hirsch">Etienne Hirsch</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3037" status="VALID">
<orgName>Neurologie et thérapeutique expérimentale</orgName>
<desc>
<address>
<addrLine>GH Pitié-Salpetrière 47, Boulevard de L'Hopital 75651 PARIS CEDEX 13</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u289.ifrns.chups.jussieu.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation active="#struct-300636" type="direct"></relation>
<relation name="U679" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300636" type="direct">
<org type="institution" xml:id="struct-300636" status="VALID">
<orgName>IFR70</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="U679" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="El Mestikawy, Salah" sort="El Mestikawy, Salah" uniqKey="El Mestikawy S" first="Salah" last="El Mestikawy">Salah El Mestikawy</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:inserm-00154872</idno>
<idno type="halId">inserm-00154872</idno>
<idno type="halUri">http://www.hal.inserm.fr/inserm-00154872</idno>
<idno type="url">http://www.hal.inserm.fr/inserm-00154872</idno>
<idno type="doi">10.1016/j.neurobiolaging.2006.02.010</idno>
<date when="2007-04">2007-04</date>
<idno type="wicri:Area/Hal/Corpus">000067</idno>
<idno type="wicri:Area/Hal/Curation">000067</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.</title>
<author>
<name sortKey="Kashani, Alireza" sort="Kashani, Alireza" uniqKey="Kashani A" first="Alireza" last="Kashani">Alireza Kashani</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Betancur, Catalina" sort="Betancur, Catalina" uniqKey="Betancur C" first="Catalina" last="Betancur">Catalina Betancur</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Giros, Bruno" sort="Giros, Bruno" uniqKey="Giros B" first="Bruno" last="Giros">Bruno Giros</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, Etienne" sort="Hirsch, Etienne" uniqKey="Hirsch E" first="Etienne" last="Hirsch">Etienne Hirsch</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3037" status="VALID">
<orgName>Neurologie et thérapeutique expérimentale</orgName>
<desc>
<address>
<addrLine>GH Pitié-Salpetrière 47, Boulevard de L'Hopital 75651 PARIS CEDEX 13</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u289.ifrns.chups.jussieu.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation active="#struct-300636" type="direct"></relation>
<relation name="U679" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300636" type="direct">
<org type="institution" xml:id="struct-300636" status="VALID">
<orgName>IFR70</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="U679" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="El Mestikawy, Salah" sort="El Mestikawy, Salah" uniqKey="El Mestikawy S" first="Salah" last="El Mestikawy">Salah El Mestikawy</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2881" status="OLD">
<orgName>Neurobiologie et Psychiatrie</orgName>
<desc>
<address>
<addrLine>9 quai Saint Bernard 75252 Paris Cedex 05</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.im3.inserm.fr/formations/unites_INSERM/U513</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U513" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="VALID">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U513" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1016/j.neurobiolaging.2006.02.010</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>Human</term>
<term>Immunoautoradiography</term>
<term>Parkinson disease</term>
<term>Prefrontal cortex</term>
<term>Putamen</term>
<term>Temporal cortex</term>
<term>VGLUT1</term>
<term>VGLUT2</term>
<term>Vesicular glutamate transporter</term>
<term>Western blot</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Glutamatergic pathways play a key role in the functional organization of neuronal circuits involved in Parkinson disease (PD). Recently, three vesicular glutamate transporters (VGLUT1-3) were identified. VGLUT1 and VGLUT2 are responsible for the uploading of glutamate into synaptic vesicles and are the first specific markers of glutamatergic neurons available. Here, we analyzed the expression of VGLUT1 and VGLUT2 in autopsy tissues of PD patients and matched controls using Western blot and immunoautoradiography. VGLUT1 and VGLUT2 expression was increased in the Parkinsonian putamen by 24% and 29%, respectively (p<0.01). In contrast, only VGLUT1 was dramatically decreased in the prefrontal and temporal cortex of PD patients (approximately 50%, p<0.01 and p<0.001, respectively). These findings demonstrate the existence of profound alterations of glutamatergic transmission in PD, which are likely to contribute to the motor and cognitive impairments associated with the disease, and should thus be taken into account in the treatment of PD.</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.</title>
<author role="aut">
<persName>
<forename type="first">Alireza</forename>
<surname>Kashani</surname>
</persName>
<idno type="halauthorid">188150</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Catalina</forename>
<surname>Betancur</surname>
</persName>
<idno type="halauthorid">117624</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Bruno</forename>
<surname>Giros</surname>
</persName>
<idno type="halauthorid">157784</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Etienne</forename>
<forename type="middle">C.</forename>
<surname>Hirsch</surname>
</persName>
<idno type="halauthorid">188151</idno>
<affiliation ref="#struct-3037"></affiliation>
</author>
<author role="crp">
<persName>
<forename type="first">Salah</forename>
<surname>El Mestikawy</surname>
</persName>
<email type="md5">72dd00bcfe664fa10c4deef430519f9f</email>
<email type="domain">creteil.inserm.fr</email>
<idno type="halauthorid">188152</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>Catalina</forename>
<surname>Betancur</surname>
</persName>
<email type="md5">8eb223d47e4d8556ca73792b6172fe6c</email>
<email type="domain">inserm.fr</email>
</editor>
<funder>This work was supported by Institut National de la Santé et de la Recherche Médicale (INSERM) and by grants from Association France Parkinson and Fédération pour la Recherche sur le Cerveau. AK was supported by a fellowship from Association France Alzheimer.</funder>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2007-06-15 11:12:43</date>
<date type="whenModified">2016-04-02 01:00:37</date>
<date type="whenReleased">2016-04-01 15:55:16</date>
<date type="whenProduced">2007-04</date>
<date type="whenEndEmbargoed">2007-06-15</date>
<ref type="file" target="http://www.hal.inserm.fr/inserm-00154872/document">
<date notBefore="2007-06-15"></date>
</ref>
<ref type="file" subtype="author" n="1" target="http://www.hal.inserm.fr/inserm-00154872/file/Kashani_Parkinson_Neurobiol_Aging_2007.pdf">
<date notBefore="2007-06-15"></date>
</ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="111046">
<persName>
<forename>Catalina</forename>
<surname>Betancur</surname>
</persName>
<email type="md5">8eb223d47e4d8556ca73792b6172fe6c</email>
<email type="domain">inserm.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">inserm-00154872</idno>
<idno type="halUri">http://www.hal.inserm.fr/inserm-00154872</idno>
<idno type="halBibtex">kashani:inserm-00154872</idno>
<idno type="halRefHtml">Neurobiol Aging, 2007, 28 (4), pp.568-78. <10.1016/j.neurobiolaging.2006.02.010></idno>
<idno type="halRef">Neurobiol Aging, 2007, 28 (4), pp.568-78. <10.1016/j.neurobiolaging.2006.02.010></idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
<idno type="stamp" n="UPMC">Université Pierre et Marie Curie</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.</title>
<author role="aut">
<persName>
<forename type="first">Alireza</forename>
<surname>Kashani</surname>
</persName>
<idno type="halauthorid">188150</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Catalina</forename>
<surname>Betancur</surname>
</persName>
<idno type="halauthorid">117624</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Bruno</forename>
<surname>Giros</surname>
</persName>
<idno type="halauthorid">157784</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Etienne</forename>
<forename type="middle">C.</forename>
<surname>Hirsch</surname>
</persName>
<idno type="halauthorid">188151</idno>
<affiliation ref="#struct-3037"></affiliation>
</author>
<author role="crp">
<persName>
<forename type="first">Salah</forename>
<surname>El Mestikawy</surname>
</persName>
<email type="md5">72dd00bcfe664fa10c4deef430519f9f</email>
<email type="domain">creteil.inserm.fr</email>
<idno type="halauthorid">188152</idno>
<affiliation ref="#struct-2881"></affiliation>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="INCOMING">27025</idno>
<title level="j">Neurobiol Aging</title>
<imprint>
<biblScope unit="volume">28</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="pp">568-78</biblScope>
<date type="datePub">2007-04</date>
<date type="dateEpub">2006-03-24</date>
</imprint>
</monogr>
<idno type="doi">10.1016/j.neurobiolaging.2006.02.010</idno>
<idno type="pubmed">16563567</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<keywords scheme="author">
<term xml:lang="en">Human</term>
<term xml:lang="en">Parkinson disease</term>
<term xml:lang="en">Vesicular glutamate transporter</term>
<term xml:lang="en">VGLUT1</term>
<term xml:lang="en">VGLUT2</term>
<term xml:lang="en">Prefrontal cortex</term>
<term xml:lang="en">Temporal cortex</term>
<term xml:lang="en">Putamen</term>
<term xml:lang="en">Western blot</term>
<term xml:lang="en">Immunoautoradiography</term>
</keywords>
<classCode scheme="mesh">Aged</classCode>
<classCode scheme="mesh">Aged, 80 and over</classCode>
<classCode scheme="mesh">Case-Control Studies</classCode>
<classCode scheme="mesh">Female</classCode>
<classCode scheme="mesh">Gene Expression Regulation</classCode>
<classCode scheme="mesh">Humans</classCode>
<classCode scheme="mesh">Male</classCode>
<classCode scheme="mesh">Middle Aged</classCode>
<classCode scheme="mesh">Nerve Tissue Proteins</classCode>
<classCode scheme="mesh">Parkinson Disease</classCode>
<classCode scheme="mesh">Postmortem Changes</classCode>
<classCode scheme="mesh">Vesicular Glutamate Transport Protein 1</classCode>
<classCode scheme="mesh">Autoradiography</classCode>
<classCode scheme="mesh">Blotting, Western</classCode>
<classCode scheme="mesh">Brain</classCode>
<classCode scheme="halDomain" n="sdv.neu">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">Glutamatergic pathways play a key role in the functional organization of neuronal circuits involved in Parkinson disease (PD). Recently, three vesicular glutamate transporters (VGLUT1-3) were identified. VGLUT1 and VGLUT2 are responsible for the uploading of glutamate into synaptic vesicles and are the first specific markers of glutamatergic neurons available. Here, we analyzed the expression of VGLUT1 and VGLUT2 in autopsy tissues of PD patients and matched controls using Western blot and immunoautoradiography. VGLUT1 and VGLUT2 expression was increased in the Parkinsonian putamen by 24% and 29%, respectively (p<0.01). In contrast, only VGLUT1 was dramatically decreased in the prefrontal and temporal cortex of PD patients (approximately 50%, p<0.01 and p<0.001, respectively). These findings demonstrate the existence of profound alterations of glutamatergic transmission in PD, which are likely to contribute to the motor and cognitive impairments associated with the disease, and should thus be taken into account in the treatment of PD.</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000065 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd -nk 000065 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Hal
   |étape=   Curation
   |type=    RBID
   |clé=     Hal:inserm-00154872
   |texte=   Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024